Kai Chen

Our review of “engineering new catalytic activities in #enzymes” is online at @NatureCatalysis, highlighting the work from @HysterLab, @JCLewisLab, @WardGroupBS, @Turner_Biocat, @RoelfesGroup, @FasanLab, Müller, Hauer, us @francesarnold lab and more. nature.com/articles/s4192…

Below is the story of the first patient treated with a prime-edited therapeutic, developed by @PrimeMedicine in a trial led by Dr. Élie Haddad and his team at CHU Sainte-Justine. This teenager suffered from chronic granulomatous disease (CGD), an immunodeficiency, and now—10 months after treatment—the patient is healthy, stable, and living with a functioning immune system. Tracy Attebury, whose story was previously told by @ginakolata @nytimes, was the second patient treated with a prime-edited therapeutic. cihr-irsc.gc.ca/e/54638.html

Delighted to share new @arcinstitute work from our group on AI-accelerated lab-in-the-loop, in @ScienceMagazine today One of the most remarkable things about biology is that it's digital. DNA, RNA, proteins: these are all sequences, and their function is directly encoded in their sequence of letters. But a protein of length N has 20^N possible variants and the vast majority are non-functional. Evolution spent billions of years finding the functional needles in this haystack through random exploration and natural selection. For modern biomedicine, we need to solve this in days to weeks.

@athavale_s @uclachem @ScienceMagazine Congrats Soumitra!

Thrilled to share the first paper from our group at UCLA, online today in Science: “Biocatalytic, Asymmetric Radical Hydrogenation of Unactivated Alkenes” @uclachem @ScienceMagazine science.org/doi/10.1126/sc…

David Baltimore, President Emeritus and the Judge Shirley Hufstedler Professor of Biology, Emeritus at Caltech and a co-recipient of the 1975 Nobel Prize in Physiology or Medicine, passed away on September 6, 2025. He was 87 years old. caltech.edu/about/news/cal…

@XueSherryGao @aiche Congratulations, Xue!

Thrilled to share I’ve been selected as the 2025 Early Career Awardee by @AIChE’s Food, Pharmaceutical & Bioengineering Division. From my first Women in ChemE Travel Grant in 2012 as a PhD student to this recognition today, I’m so grateful to my members, collaborators, & mentors.

I discuss the urgent crisis from the loss of federal support of science in the US and recent clinical gene editing breakthroughs with @WalterIsaacson & @amanpour on @AmanpourCoPBS, airing on @PBS tonight at 11 pm ET, and on @cnni earlier today. Pls share! youtube.com/watch?v=8YhJM6…

My ACS Priestley Medal address can be found here. Many stories not told in science talks... fhalab.caltech.edu/wp-content/upl…

Meet @francesarnold, 2025 Priestley Medalist, at #ACSSpring2025. Stop by the ACS Booth Theater in the Expo Hall to hear about her contributions to #chemistry and pick up a signed copy of her C&EN feature issue. RSVP: connect.discoveracs.org/cen-priestley-…

We are excited to report the discovery of TIGRs, a widely-occurring RNA-guided system found in bacteria and their viruses. TIGRs consist of a peculiar repeat region which is transcribed into RNA and processed into multiple guide RNAs to direct TIGR-associated proteins to their DNA targets. science.org/doi/10.1126/sc…

Announcing Evo 2: The largest publicly available, AI model for biology to date, capable of understanding and designing genetic code across all three domains of life. arcinstitute.org/manuscripts/Ev…

Single-molecule live-cell RNA imaging with CRISPR–Csm go.nature.com/3EJPKsM

🚀 DeepSeek-R1 is here! ⚡ Performance on par with OpenAI-o1 📖 Fully open-source model & technical report 🏆 MIT licensed: Distill & commercialize freely! 🌐 Website & API are live now! Try DeepThink at chat.deepseek.com today! 🐋 1/n

On 30 December chemistry laureate Fraser Stoddart sadly passed away at the age of 82. Stoddart's groundbreaking work in the field of supramolecular chemistry and nanotechnology has left an indelible mark on the scientific community and a forever lasting gift to society and humankind. Learn more about his work here: bit.ly/3BPmy2B

Congratulations to Broad core institute member @zhangf on receiving the National Medal of Technology and Innovation, the nation’s most prestigious honor for American innovators! broad.io/WHScience

With profound sadness, we announce the passing of Sir Fraser Stoddart, Nobel Laureate and cherished member of @NorthwesternU. His groundbreaking contributions transformed the field of #chemistry and inspired countless scientists worldwide. ➡️ bit.ly/stoddart-in-me…

@SuYapeng @Cancer Congratulations 🎉🎊 Yapeng!

Excited to share one of the key pieces of my postdoc work! Our co-first author paper in out today @Cancer Cell explores how mannose supplementation metabolically programs T cell differentiation to boost anti-tumor immunity. Paper link: authors.elsevier.com/c/1kDHf5TA51hP…

@SuYapeng Congratulations, Yapeng🎉🎉🎉

Such an incredible honor to be among this group of scientists!

Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein go.nature.com/408uNAq

@Jikkyleaks @NatureBiotech Plasmids are available on Addgene

@kaichen_1990 @NatureBiotech Can we get plasmids with that? arkmedic.info/p/would-you-li…

Thrilled to share our latest work on lipid nanoparticle (LNP) delivery of a stable CRISPR-Cas9 ribonucleoprotein (RNP) for in vivo genome editing, now published @NatureBiotech! 🧬 nature.com/articles/s4158… In this paper, we first engineered robust, efficient, and stable CRISPR-Cas9 genome-editing enzymes, iGeoCas9s, through #directedevolution of Cas9 from Geobacillus stearothermophilus (GeoCas9). We then developed an LNP-based delivery platform that successfully encapsulates and delivers iGeoCas9 RNP to various cell lines, achieving high-efficiency genome editing in vitro, including homology-directed repair (HDR) via codelivery of RNP and ssDNA templates. In the end, we demonstrated that different LNP formulations enabled tissue-specific genome editing in the liver and lungs after single intravenous injections of iGeoCas9 RNP–LNP complexes without triggering detectable immune responses. Overall, our results show that stable Cas9 RNP–LNP complexes can be a robust alternative to mRNA–LNP delivery and expand the therapeutic potential of CRISPR genome editing. Our previous study @CellCellPress illustrated why our engineered iGeoCas9 exhibits dramatic improvements in its genome editing function. The high protein stability and desired negative charge density are the key to the successful development of the LNP delivery strategy for iGeoCas9 RNPs, which outperforms mRNA+sgRNA codelivery by LNPs for genome editing. We believe this LNP delivery platform can be further extended to other editing tools, such as base editors and prime editors. Huge thanks to my collaborators @doudna_lab and in the Murthy lab for making this possible! @igisci @berkeleyMCB

@SuYapeng Huge congratulations Yapeng!

Such an incredible honor to be among this group of scientists!